AIkido Pharma Inc

NASDAQ:AIKI  
0.73
-0.02 (-2.96%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

AIkido Pharma Inc Stock, NASDAQ:AIKI

One Rockefeller Plaza, 11th floor, New York, New York 10020
United States of America
Phone: +1.12.745.1374
Number of Employees: 5

Description

AIkido Pharma, Inc. is a biotechnology development company, which engages in the provision of diversified portfolio of small-molecule anticancer and antiviral therapeutics in development. Its oncology therapeutics includes treatments for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. It also creates broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. The company was founded by Gilbert V. Levin and M. Karen Levin in 1967 and is headquartered in New York, NY.